NCT07085065Recruiting
Distraction With Virtual Reality From Pain and Anxiety for Patients With Hematological Malignancies
Virtual Reality to Reduce Pain and Anxiety in Hematological Cancer Patients Undergoing Invasive Procedures: Protocol for a Crossover Clinical Trial
Source: ClinicalTrials.gov · Last updated 25 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical trial\] is to study the effectiveness of Virtual Reality (VR) in reducing pain and anxiety during painful procedures for patients with hematological malignancies The main question\[s\] it aims to answer are: Does VR effectively reduce pain during painful procedures for patients with hematological malignancies ? Does VR effectively reduce anxiety during painful procedures for patients with hematological malignancies ? Interventional group (intra-group comparaison): This design allows each patient to act as his own control.: The intervention consists of a complete sequence involving three phases: Period 1 (standard care), a washout period of at least seven days, and Period 2 (VR session). External control group (inter-group comparaison): Patients will be assigned to the intervention group first, and then a matching external control patient will be selected based on age and type of procedure.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 365 (estimated)
- First submitted
- 10 Jul 2025
- Start date
- 1 Feb 2024
- Primary completion date
- 31 Jul 2025
- Lead sponsor
- Yesmine Amara
- Diseases
- Childhood cancers
- NCT number
- NCT07085065
What you commit to
- Study type: Interventional
- Planned participants: 365
- From 1 Feb 2024 to the primary completion date, 31 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- unstable or photosensitive epilepsy
- severe psychiatric, cognitive, or mental disorders
- Contagious diseases
Other
- hearing, visual, or inner ear impairments
- Communication difficulties
- Patients who withdraw consent
- Patient who remove the VR headset during the procedure
Who the study is looking for
- being ≥ 6 years old
- having a confirmed diagnosis of a hematological malignancy
- undergoing at least one of the following procedures: Bone Marrow Biopsy, Bone Marrow Aspiration, Lumbar Puncture, Venipuncture, or Chemotherapy.
Age in the registry: 6 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Clinical hematology department of unversity hospital of Hedi Chaker of Sfax, Tunisia Coordinator of this site? Confirm its status | Tunis | Tunisia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.